EcoDrugPlus

Ensembl ID : ENSCCRG00000037771
Gene Symbol: -
Cross references: -
229 Possible Orthologues:

Ensembl ID : ENSCCRG00000003775
Gene Symbol: -
Cross references: -
136 Possible Orthologues:

Ensembl ID : ENSCCRG00000003615
Gene Symbol: -
Cross references: -
136 Possible Orthologues:

Ensembl ID : ENSCCRG00000003476
Gene Symbol: -
Cross references: -
158 Possible Orthologues:

Ensembl ID : ENSCCRG00000038023
Gene Symbol: -
Cross references: -
159 Possible Orthologues:

Ensembl ID : ENSCCRG00000078267
Gene Symbol: -
Cross references: -
336 Possible Orthologues:

Ensembl ID : ENSCCRG00000041272
Gene Symbol: -
Cross references: -
247 Possible Orthologues:

Ensembl ID : ENSCCRG00000077991
Gene Symbol: -
Cross references: -
298 Possible Orthologues:

Ensembl ID : ENSCCRG00000068056
Gene Symbol: -
Cross references: -
165 Possible Orthologues:

Ensembl ID : ENSCCRG00000067765
Gene Symbol: -
Cross references: -
190 Possible Orthologues:

Ensembl ID : ENSCCRG00000055039
Gene Symbol: -
Cross references: -
239 Possible Orthologues:

Ensembl ID : ENSCCRG00000046613
Gene Symbol: -
Cross references: -
150 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).